Page last updated: 2024-08-17

levodopa and 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine

levodopa has been researched along with 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bezard, E; Girard, F; Keywood, C; Li, Q; Mutel, V; Pioli, EY; Poli, SM; Rascol, O; Tison, F	1
Bezard, E; Corvol, JC; Durif, F; Eggert, K; Goetz, CG; Isaacson, S; Keywood, C; Lew, M; Poli, SM; Rascol, O; Tison, F; Trenkwalder, C; Wakefield, M	1

Trials

1 trial(s) available for levodopa and 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine

Article	Year
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:9 Topics: Aged; Dopamine Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pyridines; Receptor, Metabotropic Glutamate 5	2016

Article

Year

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:9

Topics: Aged; Dopamine Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pyridines; Receptor, Metabotropic Glutamate 5

2016

Other Studies

1 other study(ies) available for levodopa and 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine

Article	Year
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:8 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Imidazoles; Levodopa; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Pyridines; Receptor, Metabotropic Glutamate 5; Severity of Illness Index; Time Factors	2014

Article

Year

The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model.

Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:8

Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Imidazoles; Levodopa; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Pyridines; Receptor, Metabotropic Glutamate 5; Severity of Illness Index; Time Factors

2014